Mark Austin
Financieel Directeur/CFO bij PERSPECTIVE THERAPEUTICS, INC.
Vermogen: 115 961 $ op 31-05-2024
Actieve functies van Mark Austin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-07-2017 | - |
| Financieel Directeur/CFO | 01-07-2017 | - | |
| Bedrijfssecretaris | 15-09-2020 | - |
Loopbaan van Mark Austin
Eerdere bekende functies van Mark Austin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
KPMG Advisory SP ZOO Spolka Komandytowa
 KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Corporate Officer/Principal | 01-01-2009 | 01-07-2017 |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Comptroller/Controller/Auditor | 24-07-2017 | - |
| Financieel Directeur/CFO | 24-07-2017 | - | |
| Bedrijfssecretaris | 03-12-2018 | - |
Opleiding van Mark Austin
| Santa Clara University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Polen | 2 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Corporate Secretary | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Finance |
- Beurs
- Insiders
- Mark Austin
- Ervaring
